These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 25363875)

  • 1. Pre-radiotherapy identification of individual genomic profile to avoid, by resort to customized radiosensitizers, the risk of radioresistance development in patients with localized prostate cancer: author reply.
    Berlin A; Dal Pra A; Bristow RG
    Br J Radiol; 2015 Jan; 88(1045):20140701. PubMed ID: 25363875
    [No Abstract]   [Full Text] [Related]  

  • 2. Pre-radiotherapy identification of individual genomic profile to avoid, by resort to customized radiosensitizers, the risk of radioresistance development in patients with localized prostate cancer.
    Alberti C
    Br J Radiol; 2015 Jan; 88(1045):20140630. PubMed ID: 25363844
    [No Abstract]   [Full Text] [Related]  

  • 3. Prostate cancer: radioresistance molecular target-related markers and foreseeable modalities of radiosensitization.
    Alberti C
    Eur Rev Med Pharmacol Sci; 2014 Aug; 18(16):2275-82. PubMed ID: 25219826
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical results from first use of prostate stent as fiducial for radiotherapy of prostate cancer.
    Carl J; Nielsen J; Holmberg M; Larsen EH; Fabrin K; Fisker RV
    Acta Oncol; 2011 May; 50(4):547-54. PubMed ID: 21174520
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Array CGH as a potential predictor of radiocurability in intermediate risk prostate cancer.
    Ishkanian AS; Zafarana G; Thoms J; Bristow RG
    Acta Oncol; 2010 Oct; 49(7):888-94. PubMed ID: 20590366
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PSA after definitive radiotherapy for clinically localized prostate cancer.
    Goad JR; Chang SJ; Ohori M; Scardino PT
    Urol Clin North Am; 1993 Nov; 20(4):727-36. PubMed ID: 7505981
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Controversies in prostate cancer radiotherapy: consensus development.
    Lukka H; Warde P; Pickles T; Morton G; Brundage M; Souhami L;
    Can J Urol; 2001 Aug; 8(4):1314-22. PubMed ID: 11564274
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Localized prostate cancer. Diagnosis and treatment.
    Bulbul MA
    J Med Liban; 1993; 41(4):218-22. PubMed ID: 7543154
    [No Abstract]   [Full Text] [Related]  

  • 9. Prostate cancer: 7. Radiation therapy for localized disease.
    Warde P; Catton C; Gospodarowicz MK
    CMAJ; 1998 Dec; 159(11):1381-8. PubMed ID: 9861209
    [No Abstract]   [Full Text] [Related]  

  • 10. [Image-guided radiotherapy for prostate cancer].
    Lohr F; Boda-Heggemann J; Wenz F; Wiegel T
    Aktuelle Urol; 2007 Sep; 38(5):386-91; discussion 385. PubMed ID: 17907065
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predictive value of epithelial-mesenchymal-transition (EMT) signature and PARP-1 in prostate cancer radioresistance.
    Stark TW; Hensley PJ; Spear A; Pu H; Strup SS; Kyprianou N
    Prostate; 2017 Dec; 77(16):1583-1591. PubMed ID: 29063620
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Results of percutaneous radiotherapy of localized prostatic carcinoma (author's transl)].
    Schmitt G; Lenz W; Mellin P; Scherer E; Schulte-Vels K
    Dtsch Med Wochenschr; 1980 Mar; 105(11):365-8. PubMed ID: 7363774
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting MicroRNAs in Prostate Cancer Radiotherapy.
    Ni J; Bucci J; Chang L; Malouf D; Graham P; Li Y
    Theranostics; 2017; 7(13):3243-3259. PubMed ID: 28900507
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prostate cancer radiotherapy: potential applications of metal nanoparticles for imaging and therapy.
    Coulter JA; Butterworth KT; Jain S
    Br J Radiol; 2015 Oct; 88(1054):20150256. PubMed ID: 26051659
    [TBL] [Abstract][Full Text] [Related]  

  • 15. When should the seminal vesicles be included in the target volume in prostate radiotherapy?
    Bayman NA; Wylie JP
    Clin Oncol (R Coll Radiol); 2007 Jun; 19(5):302-7. PubMed ID: 17448647
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Curative radiotherapy of localized prostate cancer. Treatment methods and results].
    Schwarz R
    Urologe A; 2003 Sep; 42(9):1212-20. PubMed ID: 14504754
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Emerging roles of radioresistance in prostate cancer metastasis and radiation therapy.
    Chang L; Graham PH; Hao J; Bucci J; Cozzi PJ; Kearsley JH; Li Y
    Cancer Metastasis Rev; 2014 Sep; 33(2-3):469-96. PubMed ID: 24445654
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Re: Diffusion-weighted MR imaging in early assessment of tumor response to radiotherapy in high-risk prostate cancer.
    Taneja SS
    J Urol; 2015 Feb; 193(2):539-40. PubMed ID: 25617273
    [No Abstract]   [Full Text] [Related]  

  • 19. [How to treat a localized prostate cancer: irradiation, surgery or watchful waiting?].
    Zellweger T; Gasser T
    Praxis (Bern 1994); 2005 Aug; 94(34):1307-8. PubMed ID: 16170999
    [No Abstract]   [Full Text] [Related]  

  • 20. Prospective study of fatigue in localized prostate cancer patients undergoing radiotherapy.
    Monga U; Kerrigan AJ; Thornby J; Monga TN
    Radiat Oncol Investig; 1999; 7(3):178-85. PubMed ID: 10406060
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.